BioPharmGuy logo
Sponsored By:
Trianni Inc.
BioPharmGuy Database
Emery Pharma
TyrNovo is defunct.

Fate: Bought by Kitov Therapeutics, Jan 2017, $2M + $1.8M stock


------------------
If you believe any of this information is incorrect, please let us know.